Literature DB >> 24421868

Photoletter to the editor: Diffuse cocaine-related purpura.

Debjeet Sarkar1, Hussein A Kammona1, Leonard N Lamsen1, Bradley A McAbee1, Christopher T Clark2, Solomon S Lee2, Shane E Kelley3.   

Abstract

Diffuse purpura is an uncommon skin manifestation found in platelet and coagulation disorders, meningococcemia, vasculitides and cocaine use. Reports of cocaine-related purpura predominantly involve adulteration with the anti-helminthic, levamisole. Levamisole enhances the effects of cocaine and is known to cause vasculitis. Recently, the CDC also released an advisory of oxymorphone being used intravenously causing thrombogenic thrombocytopenic purpura (TTP). We report the case of a patient with diffuse purpura ultimately diagnosed with cocaine-related thrombogenic vasculopathy. In the current environment of adulterated cocaine usage and increased prescription narcotic abuse, it is crucial to investigate substance abuse as a cause of diffuse purpura.

Entities:  

Keywords:  cocaine; levamisole; oxymorphone; purpura

Year:  2013        PMID: 24421868      PMCID: PMC3888784          DOI: 10.3315/jdcr.2013.1159

Source DB:  PubMed          Journal:  J Dermatol Case Rep        ISSN: 1898-7249


  5 in total

1.  Reversible retiform purpura: a sign of cocaine use.

Authors:  Christina Han; Gayatri Sreenivasan; Jan P Dutz
Journal:  CMAJ       Date:  2011-03-14       Impact factor: 8.262

2.  Retiform purpura: a new stigmata of illicit drug use?

Authors:  Lauren Geller; Talley B Whang; Stephen E Mercer; Robert Phelps
Journal:  Dermatol Online J       Date:  2011-02-15

Review 3.  Vasculopathy related to cocaine adulterated with levamisole: A review of the literature.

Authors:  Timothy Pearson; Matthew Bremmer; Jared Cohen; Marcia Driscoll
Journal:  Dermatol Online J       Date:  2012-07-15

4.  Limited cutaneous vasculitis associated with levamisole-adulterated cocaine.

Authors:  Ralph Yachoui; Sharon L Kolasinski; Hala Eid
Journal:  J Clin Med Res       Date:  2012-09-12

5.  Thrombotic thrombocytopenic purpura (TTP)-like illness associated with intravenous Opana ER abuse--Tennessee, 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-01-11       Impact factor: 17.586

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.